All NIH Funding Opportunities and Notices

• NIH to Transition Payment for Individual Fellowships at Foreign and Federal Sponsoring Institutions, and Awards to Federal Institutions to Payment Management System Subaccounts in FY 2014
  (NOT-OD-13-111)
  National Institutes of Health
  

• NIH Domestic Awards to Transition to Payment Management System Subaccounts in FY 2014
  (NOT-OD-13-112)
  National Institutes of Health
  

• Notice of Correction in PA-13-314 "Small Grants on Primary Immunodeficiency Diseases (R03)"
  (NOT-AI-13-062)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Correction in PA-13-315 "Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)"
  (NOT-AI-13-063)
  National Institute of Allergy and Infectious Diseases
  

• Notice to Clarify Placement of the Research Translation Plan in RFA-ES-13-010 "Biogeochemical Interactions Affecting Bioavailability for in situ Remediation of Hazardous Substances (R01)"
  (NOT-ES-13-010)
  National Institute of Environmental Health Sciences
  

• Notice of Correction to PAR-13-290 "Institutional Research and Academic Career Development Awards (IRACDA) (K12)"
  (NOT-GM-13-132)
  National Institute of General Medical Sciences
  

• Notice of Correction to Confirm that AIDS Applications Are Accepted for PAR-13-009 "Secondary Dataset Analyses in Heart, Lung, and Blood Diseases"
  (NOT-HL-13-195)
  National Heart, Lung, and Blood Institute
  

• Notice to Clarify the Placement of the Transcript in Applications Submitted to PAR-12-103 "Mental Health Research Dissertation Grant to Increase Diversity (R36)"
  (NOT-MH-13-021)
  National Institute of Mental Health
  

• Notice of NINR Withdrawal from PA-12-038 Research to Advance Vaccine Safety (R21)
  (NOT-NR-13-014)
  National Institute of Nursing Research
  

• Notice of NINR Withdrawal from PA-12-037 Research to Advance Vaccine Safety (R01)
  (NOT-NR-13-015)
  National Institute of Nursing Research
  

• (none)

• Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01)
  (PAR-13-325)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21)
  (PAR-13-326)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Development of Appropriate Pediatric Formulations and Drug Delivery Systems (R03)
  (PAR-13-344)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Development of Appropriate Pediatric Formulations and Drug Delivery Systems (R43)
  (PAR-13-345)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Advancing Translational Sciences
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Development of Appropriate Pediatric Formulations and Drug Delivery Systems STTR (R41)
  (PAR-13-346)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Advancing Translational Sciences
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

  Past Tables of Contents

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892